Company
Cambrian Biopharma
Cambrian Bio is a clinical-stage drug development company developing therapeutics that will redefine healthcare in the 21st century.
Also known as CAMBRIAN, Cambrian Bio, Cambrian BioPharma Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Cambrian BioPharma Inc
- cambrianbio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are a dedicated team of scientists and business experts who share a common goal: to improve the quality of life for people all over the world. To do this, we are developing medicines that target the metabolic pathways that decline with age, first as treatments and then as preventive medicines.
Funding snapshot
- Total raised
- $148MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $124M2026-06-30
Funding rounds
- Round, 2026
- $124M2026-06-30, SEC form D sold, 80 investors
- Round, 2023
- $23M2023-06-02, SEC form D sold, 30 investors
- Round, 2021
- $92.2M2021-10-13, SEC form D sold, 56 investors
- Round, 2020
- $28.4M2020-10-20, SEC form D sold, 30 investors
- Round, 2019
- $4.8M2019-10-29, SEC form D sold, 5 investors
Products
- Other
- ATX-304
Loading relationship preview